Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ENCYSIVE PHARMACEUTICALS INC | 69,076,466 | reported | 14 Apr 2008 | tx 12+7,493,080 |
| Allogene Therapeutics, Inc. | 22,032,040 | reported | 15 Oct 2018 | tx 3+22,032,040−4,185,997 |
| Pyxis Oncology, Inc. | 5,952,263 | reported | 17 Mar 2023 | tx 2+3,623,188 |
| ICAGEN INC | 5,393,380 | reported | 19 Sept 2011 | tx 7+9,778,222 |
| ARQULE INC | 3,273,679 | reported | 17 Dec 2003 | tx 2+1,290,324 |
| Mirna Therapeutics, Inc. | 2,489,364 | reported | 06 Oct 2015 | tx 5+2,489,364−1,539,224 |
| Neurogene Inc. | 1,193,541 | reported | 10 Aug 2015 | tx 22+1,235,330−1,222,530 |
| Viatris Inc | 0 | reported | 16 Nov 2020 | tx 2+689,873,947−689,874,047 |
| Zoetis Inc. | 0 | reported | 24 Jun 2013 | tx 6+413,900,000−913,900,000 |
| SpringWorks Therapeutics, Inc. | 0 | reported | 17 Sept 2019 | tx 7+4,593,847−29,903,071 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Aug 2024 | TENDER | ARYA Sciences Acquisition Corp II | 27,349,211 | 45.00 USD | |
| 17 Mar 2023 | PURCHASE | Pyxis Oncology, Inc. | 1,811,594 | 2.76 USD | |
| 18 Dec 2020 | CONVERSION | BioAtla, Inc. | 2,238,090 | — | |
| 18 Dec 2020 | CONVERSION | BioAtla, Inc. | 2,238,090 | — | deriv |
| 16 Nov 2020 | OTHER | Viatris Inc | 689,874,047 | 0.00 USD | |
| 13 Nov 2020 | OTHER | Viatris Inc | 689,873,947 | 0.00 USD | |
| 27 Oct 2020 | PURCHASE | ARYA Sciences Acquisition Corp II | 1,200,000 | 10.00 USD | first after silence |
| 17 Sept 2019 | PURCHASE | SpringWorks Therapeutics, Inc. | 50,000 | 18.00 USD | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 526,602 | — | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 978,194 | — | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 3,039,051 | — | |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 20,000,000 | 0.00 USD | deriv |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 3,465,571 | 0.00 USD | deriv |
| 17 Sept 2019 | CONVERSION | SpringWorks Therapeutics, Inc. | 6,437,500 | 0.00 USD | deriv |
| 15 Oct 2018 | CONVERSION | Allogene Therapeutics, Inc. | 21,976,484 | — | |
| 15 Oct 2018 | PURCHASE | Allogene Therapeutics, Inc. | 55,556 | 18.00 USD | first after silence |
| 15 Oct 2018 | CONVERSION | Allogene Therapeutics, Inc. | 4,185,997 | 0.00 USD | deriv |
| 10 Oct 2017 | CONVERSION | RHYTHM PHARMACEUTICALS, INC. | 447,514 | — | |
| 10 Oct 2017 | PURCHASE | RHYTHM PHARMACEUTICALS, INC. | 40,000 | 17.00 USD | first after silence |
| 10 Oct 2017 | CONVERSION | RHYTHM PHARMACEUTICALS, INC. | 940,125 | — | |
| 10 Oct 2017 | CONVERSION | RHYTHM PHARMACEUTICALS, INC. | 940,125 | 0.00 USD | deriv |
| 10 Oct 2017 | CONVERSION | RHYTHM PHARMACEUTICALS, INC. | 447,514 | 0.00 USD | deriv |
| 05 Oct 2015 | CONVERSION | Mirna Therapeutics, Inc. | 1,539,224 | 0.00 USD | |
| 06 Oct 2015 | OTHER | Mirna Therapeutics, Inc. | 235,855 | 7.00 USD | |
| 06 Oct 2015 | PURCHASE | Mirna Therapeutics, Inc. | 714,285 | 7.00 USD | first after silence |
5 purchases reported after at least 12 months of silence — most recent on 27 Oct 2020.